Phibro Animal Health(DE:PB8)
€30.401.20 (-1.94%)
DE:PB8
Phibro Animal Health financials statements
€30.40
At close:1.20 (-1.94%)
Phibro Animal Health (PB8) Ratios
1 Followers
Phibro Animal Health Ratios
DE:PB8's free cash flow for Q1 2027 was $7.30M. For the 2027 fiscal year, DE:PB8's free cash flow was decreased by $-18.78M and operating cash flow was $26.08M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.96 | 2.76 | 2.94 | 3.33 | 2.97 |
| Quick Ratio | 1.27 | 1.25 | 1.64 | 1.75 | 1.61 |
| Cash Ratio | 0.19 | 0.23 | 0.35 | 0.23 | 0.39 |
| Solvency Ratio | 0.14 | 0.09 | 0.05 | 0.10 | 0.12 |
| Operating Cash Flow Ratio | 0.22 | 0.27 | 0.43 | 0.08 | 0.17 |
| Short-Term Operating Cash Flow Coverage | 2.76 | 4.93 | 2.94 | 0.60 | 2.11 |
| Net Current Asset Value | $ -180.26M | $ -264.61M | $ -124.55M | $ -103.17M | $ -103.03M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.53 | 0.56 | 0.53 | 0.52 | 0.50 |
| Debt-to-Equity Ratio | 2.05 | 2.67 | 2.05 | 1.81 | 1.79 |
| Debt-to-Capital Ratio | 0.67 | 0.73 | 0.67 | 0.64 | 0.64 |
| Long-Term Debt-to-Capital Ratio | 0.65 | 0.71 | 0.64 | 0.62 | 0.61 |
| Financial Leverage Ratio | 3.89 | 4.76 | 3.83 | 3.44 | 3.55 |
| Debt Service Coverage Ratio | 2.74 | 2.57 | 1.17 | 2.10 | 3.47 |
| Interest Coverage Ratio | 4.17 | 3.32 | 2.43 | 4.00 | 6.53 |
| Debt to Market Cap | 0.57 | 0.69 | 0.71 | 0.86 | 0.56 |
| Interest Debt Per Share | 20.60 | 19.62 | 13.52 | 13.03 | 11.92 |
| Net Debt to EBITDA | 3.08 | 4.72 | 6.59 | 4.42 | 3.38 |
| Profitability Margins | |||||
| Gross Profit Margin | 33.71% | 30.85% | 30.77% | 30.50% | 30.29% |
| EBIT Margin | 12.18% | 7.81% | 3.23% | 7.36% | 8.96% |
| EBITDA Margin | 15.58% | 11.33% | 6.79% | 10.84% | 12.43% |
| Operating Profit Margin | 13.07% | 8.52% | 5.24% | 7.35% | 8.38% |
| Pretax Profit Margin | 9.05% | 5.25% | 1.07% | 5.53% | 7.68% |
| Net Profit Margin | 6.57% | 3.72% | 0.24% | 3.33% | 5.22% |
| Continuous Operations Profit Margin | 6.57% | 3.72% | 0.24% | 3.33% | 5.22% |
| Net Income Per EBT | 72.60% | 70.98% | 22.13% | 60.30% | 67.99% |
| EBT Per EBIT | 69.21% | 61.55% | 20.47% | 75.26% | 91.57% |
| Return on Assets (ROA) | 6.64% | 3.55% | 0.25% | 3.36% | 5.28% |
| Return on Equity (ROE) | 25.87% | 16.89% | 0.94% | 11.54% | 18.74% |
| Return on Capital Employed (ROCE) | 16.75% | 10.35% | 6.85% | 9.03% | 10.66% |
| Return on Invested Capital (ROIC) | 11.81% | 7.18% | 1.45% | 5.26% | 7.05% |
| Return on Tangible Assets | 7.07% | 3.82% | 0.27% | 3.78% | 6.04% |
| Earnings Yield | 7.82% | 4.67% | 0.35% | 5.88% | 6.35% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.36 | 5.69 | 6.01 | 5.98 | 5.66 |
| Payables Turnover | 7.90 | 6.49 | 8.23 | 9.20 | 6.87 |
| Inventory Turnover | 1.88 | 2.02 | 2.65 | 2.45 | 2.53 |
| Fixed Asset Turnover | 4.11 | 3.27 | 4.22 | 4.23 | 4.64 |
| Asset Turnover | 1.01 | 0.95 | 1.04 | 1.01 | 1.01 |
| Working Capital Turnover Ratio | 2.67 | 2.84 | 2.52 | 2.49 | 2.65 |
| Cash Conversion Cycle | 205.35 | 188.90 | 154.20 | 170.42 | 155.40 |
| Days of Sales Outstanding | 57.41 | 64.20 | 60.78 | 61.02 | 64.51 |
| Days of Inventory Outstanding | 194.15 | 180.99 | 137.75 | 149.07 | 144.01 |
| Days of Payables Outstanding | 46.21 | 56.28 | 44.33 | 39.66 | 53.12 |
| Operating Cycle | 251.56 | 245.19 | 198.53 | 210.09 | 208.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.70 | 1.98 | 2.16 | 0.33 | 0.78 |
| Free Cash Flow Per Share | 0.24 | 1.03 | 1.14 | -0.95 | -0.13 |
| Dividend Paid and CapEx Coverage Ratio | 0.88 | 1.39 | 1.44 | 0.19 | 0.56 |
| Capital Expenditure Coverage Ratio | 1.17 | 2.09 | 2.12 | 0.26 | 0.85 |
| Operating Cash Flow Coverage Ratio | 0.09 | 0.11 | 0.17 | 0.03 | 0.07 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.06 | 0.09 | 0.01 | 0.03 |
| Free Cash Flow Yield | 0.77% | 4.04% | 6.72% | -6.94% | -0.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.76 | 21.46 | 285.67 | 17.02 | 15.76 |
| Price-to-Sales (P/S) Ratio | 0.84 | 0.80 | 0.68 | 0.57 | 0.82 |
| Price-to-Book (P/B) Ratio | 3.31 | 3.62 | 2.69 | 1.96 | 2.95 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 129.22 | 24.73 | 14.89 | -14.42 | -143.61 |
| Price-to-Operating Cash Flow Ratio | 18.49 | 12.91 | 7.88 | 41.69 | 24.48 |
| Price-to-Earnings Growth (PEG) Ratio | 0.12 | 0.01 | -3.09 | -0.51 | -1.62 |
| Enterprise Value Multiple | 8.47 | 11.77 | 16.58 | 9.65 | 10.00 |
| Enterprise Value | 2.00B | 1.73B | 1.15B | 1.02B | 1.17B |
| EV to EBITDA | 8.47 | 11.77 | 16.58 | 9.65 | 10.00 |
| EV to Sales | 1.32 | 1.33 | 1.13 | 1.05 | 1.24 |
| EV to Free Cash Flow | 202.94 | 41.31 | 24.70 | -26.60 | -217.05 |
| EV to Operating Cash Flow | 29.04 | 21.57 | 13.07 | 76.90 | 37.00 |
| Tangible Book Value Per Share | 7.28 | 4.68 | 3.88 | 4.30 | 3.59 |
| Shareholders’ Equity Per Share | 9.49 | 7.05 | 6.34 | 6.97 | 6.48 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.27 | 0.29 | 0.78 | 0.40 | 0.32 |
| Revenue Per Share | 37.39 | 32.01 | 25.13 | 24.14 | 23.27 |
| Net Income Per Share | 2.46 | 1.19 | 0.06 | 0.81 | 1.21 |
| Tax Burden | 0.73 | 0.71 | 0.22 | 0.60 | 0.68 |
| Interest Burden | 0.74 | 0.67 | 0.33 | 0.75 | 0.86 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.21 | 0.22 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.69 | 1.66 | 36.26 | 0.41 | 0.64 |
Currency in USD
